5D Patient Journey, Inc.
Biotechnology · NEW ROCHELLE, NY
BiotechnologySEC Form D
5D Patient Journey, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 31, 2026, reporting $80 raised.
Incorporated in Delaware and based in NEW ROCHELLE, NY, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that 5D Patient Journey, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Eric SchadtExecutive Officer · Director
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised